Acorah Software Products - Accounts Production 16.1.200 false true 31 December 2023 1 March 2023 false 1 January 2024 31 December 2024 31 December 2024 12437885 Dr Andreas Halner Dr Jian Rui Liu Mr Marcus Delano East Mr Bradley Wilson Ms Gemma Sturt Dr Annie Theriault iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12437885 2023-12-31 12437885 2024-12-31 12437885 2024-01-01 2024-12-31 12437885 frs-core:CurrentFinancialInstruments 2024-12-31 12437885 frs-core:ComputerEquipment 2024-12-31 12437885 frs-core:ComputerEquipment 2024-01-01 2024-12-31 12437885 frs-core:ComputerEquipment 2023-12-31 12437885 frs-core:PlantMachinery 2024-12-31 12437885 frs-core:PlantMachinery 2024-01-01 2024-12-31 12437885 frs-core:PlantMachinery 2023-12-31 12437885 frs-core:SharePremium 2024-12-31 12437885 frs-core:ShareCapital 2024-12-31 12437885 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 12437885 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12437885 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 12437885 frs-bus:SmallEntities 2024-01-01 2024-12-31 12437885 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12437885 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12437885 frs-bus:Director1 2024-01-01 2024-12-31 12437885 frs-bus:Director2 2024-01-01 2024-12-31 12437885 frs-bus:Director3 2024-01-01 2024-12-31 12437885 frs-bus:Director4 2024-01-01 2024-12-31 12437885 frs-bus:Director5 2024-01-01 2024-12-31 12437885 frs-bus:Director6 2024-01-01 2024-12-31 12437885 frs-countries:EnglandWales 2024-01-01 2024-12-31 12437885 2023-02-28 12437885 2023-12-31 12437885 2023-03-01 2023-12-31 12437885 frs-core:CurrentFinancialInstruments 2023-12-31 12437885 frs-core:SharePremium 2023-12-31 12437885 frs-core:ShareCapital 2023-12-31 12437885 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 12437885
Oxford Cancer Analytics Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 12437885
31 December 2024 31 December 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 221,407 278,234
221,407 278,234
CURRENT ASSETS
Debtors 5 403 1,395
Investments 6 - 991,583
Cash at bank and in hand 8,188,555 751,725
8,188,958 1,744,703
Creditors: Amounts Falling Due Within One Year 7 (22,102 ) (14,685 )
NET CURRENT ASSETS (LIABILITIES) 8,166,856 1,730,018
TOTAL ASSETS LESS CURRENT LIABILITIES 8,388,263 2,008,252
NET ASSETS 8,388,263 2,008,252
CAPITAL AND RESERVES
Called up share capital 8 243 161
Share premium account 12,705,355 4,272,518
Profit and Loss Account (4,317,335 ) (2,264,427 )
SHAREHOLDERS' FUNDS 8,388,263 2,008,252
Page 1
Page 2
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Andreas Halner
Director
14 March 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Oxford Cancer Analytics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12437885 . The registered office is 696, Bioescalator, Innovationbuilding, Oldroadcampus, Roosevelt Drive, Headington, Oxford, OX3 7FZ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Lab Equipment 25% straight line
Computer Equipment 25% straight line
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 13 (2023: 11)
13 11
4. Tangible Assets
Lab Equipment Computer Equipment Total
£ £ £
Cost
As at 1 January 2024 361,501 3,428 364,929
Additions 42,131 3,742 45,873
As at 31 December 2024 403,632 7,170 410,802
Depreciation
As at 1 January 2024 85,473 1,222 86,695
Provided during the period 100,908 1,792 102,700
As at 31 December 2024 186,381 3,014 189,395
...CONTINUED
Page 3
Page 4
Net Book Value
As at 31 December 2024 217,251 4,156 221,407
As at 1 January 2024 276,028 2,206 278,234
5. Debtors
31 December 2024 31 December 2023
£ £
Due within one year
Other debtors 403 747
Net wages - 648
403 1,395
6. Current Asset Investments
31 December 2024 31 December 2023
£ £
Short term deposits - 991,583
7. Creditors: Amounts Falling Due Within One Year
31 December 2024 31 December 2023
£ £
Other taxes and social security 22,013 14,673
Net wages 89 -
Directors' loan accounts - 12
22,102 14,685
8. Share Capital
31 December 2024 31 December 2023
£ £
Allotted, Called up and fully paid 243 161
Page 4